United States · FDA National Drug Code directory
NADH Plus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43857-0023_14ebc265-2136-4ca6-bd22-d8f6a0801947
- Product NDC
- 43857-0023
- Form
- SPRAY
- Composition / generic term
- Nadidum, Adenosinum Cyclophosphoricum, Calcium D-Pantothenate, Cholinum, Riboflavinum, Ubidecarenonum, Dimethyl Glycine
- Labeler
- BioActive Nutritional
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20120531
- Source listing expiry
- 20271231
Source-listed ingredients
- NADIDE — 4 [hp_X]/mL
- ADENOSINE CYCLIC PHOSPHATE — 6 [hp_X]/mL
- CALCIUM PANTOTHENATE — 6 [hp_X]/mL
- CHOLINE HYDROXIDE — 6 [hp_X]/mL
- RIBOFLAVIN — 6 [hp_X]/mL
- UBIDECARENONE — 6 [hp_X]/mL
- N,N-DIMETHYLGLYCINE — 7 [hp_X]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, SPRAY (43857-0023-1) · 43857-0023-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →